Hysterectomy for the treatment of gynecologic malignancy.
The current literature shows that minimally invasive hysterectomy for cancer is relatively safe and provides benefits in terms of blood loss and length of stay with less or equal complication rates over laparotomy. These benefits may even be greater in the morbidly obese and those with other comorbidities. Available techniques include laparotomy, laparoscopy, single-site laparoscopy, robotics, and single-site robotics. Collection of comprehensive and reliable data on complications and outcomes will prove to be the key in defining the role of new techniques in the treatment of women with gynecologic malignancies.
Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, The Ohio State University College of Medicine, Columbus, Ohio.
Floor J
FJ
Backes
Jeffrey M
JM
Fowler
D016889:Endometrial Neoplasms / Q000601:surgery*; D005260:Female; D006801:Humans; D007044:Hysterectomy / Q000191:economics / Q000379:methods*; D010535:Laparoscopy / Q000191:economics / Q000379:methods*; D019060:Minimally Invasive Surgical Procedures / Q000191:economics / Q000379:methods*; D009366:Neoplasm Seeding; D012371:Robotics / Q000191:economics / Q000379:methods*; D002583:Uterine Cervical Neoplasms / Q000601:surgery*; D014594:Uterine Neoplasms / Q000601:surgery